Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal eye physiology (HP:0012373)help
Parent Node:
expand
Abnormality of vision (HP:0000504)help
..Starting node
..expand
Blurred vision (HP:0000622)help
Term ID: 622
Name: Blurred vision
Synonym: Blurred vision
Definition: Lack of sharpness of vision resulting in the inability to see fine detail.
Comments:
Reference: HP:0000622
Genes and Diseases:
 
       Child Nodes:
........expandTransient unilateral blurring of vision (HP:0001125) help

 Sister Nodes: 
..expandAbnormality of binocular vision (HP:0011514) help
..expandAmaurosis fugax (HP:0100576) help
..expandBradyopsia (HP:0030511) help
..expandColor vision defect (HP:0000551) help
..expandDifficulty adjusting to changes in luminance (HP:0030512) help
..expandHemeralopia (HP:0012047) help
..expandMetamorphopsia (HP:0012508) help
..expandNyctalopia (HP:0000662) help
..expandPhotophobia (HP:0000613) help
..expandPhotopsia (HP:0030786) help
..expandPoor visual behavior for age (HP:0025152) help
..expandReduced visual acuity (HP:0007663) help
..expandVisual field defect (HP:0001123) help
..expandVisual impairment (HP:0000505) help
..expandVisual loss (HP:0000572) help
..expandVitreous floaters (HP:0100832) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0000622HP:0000622Blurred vision0ABCA1 CL E G H19425ORPHA124055029600046
HP:0000622HP:0000622Blurred vision0APOA1 CL E G H335425ORPHA17794600107680
HP:0000622HP:0000622Blurred vision0ATP1A2 CL E G H477602481Familial hemiplegic migraine type 2602481C1865322OMIM199706800182340
HP:0000622HP:0000622Blurred vision0COL4A1 CL E G H1282607595Brain small vessel disease with hemorrhage607595C1843512OMIM11147842202120130
HP:0000622HP:0000622Blurred vision0HLA-A CL E G H3105179Macrothrombocytopenia progressive deafnessORPHA177184931142800
HP:0000622HP:0000622Blurred vision0KCNA1 CL E G H373637612ORPHA1483846218176260
HP:0000622HP:0000622Blurred vision0KCNA1 CL E G H3736160120Episodic ataxia type 1160120C1719788OMIM1483846218176260
HP:0000622HP:0000622Blurred vision0MAPT CL E G H4137601104Progressive supranuclear ophthalmoplegia601104C0038868OMIM11204636893157140
HP:0000622HP:0000622Blurred vision0MT-ATP6 CL E G H4508104ORPHA17414516060
HP:0000622HP:0000622Blurred vision0MT-CO1 CL E G H4512104ORPHA17419516030
HP:0000622HP:0000622Blurred vision0MT-CO3 CL E G H4514104ORPHA17422516050
HP:0000622HP:0000622Blurred vision0MT-CYB CL E G H4519104ORPHA17427516020
HP:0000622HP:0000622Blurred vision0MT-ND1 CL E G H4535104ORPHA17455516000
HP:0000622HP:0000622Blurred vision0MT-ND2 CL E G H4536104ORPHA17456516001
HP:0000622HP:0000622Blurred vision0MT-ND4 CL E G H4538104ORPHA17459516003
HP:0000622HP:0000622Blurred vision0MT-ND4L CL E G H4539104ORPHA17460516004
HP:0000622HP:0000622Blurred vision0MT-ND5 CL E G H4540104ORPHA17461516005
HP:0000622HP:0000622Blurred vision0MT-ND6 CL E G H4541104ORPHA17462516006
HP:0000622HP:0000622Blurred vision0NDUFS2 CL E G H4720104ORPHA1241357708602985
HP:0000622HP:0000622Blurred vision0NLRP3 CL E G H114548148200Keratitis fugax hereditaria148200C1835697OMIM114258316400606416
HP:0000622HP:0000622Blurred vision0NOP56 CL E G H10528276198ORPHA114315911614154
HP:0000622HP:0000622Blurred vision0SCN9A CL E G H6335133020Primary erythromelalgia133020C0014805OMIM1129142710597603415
HP:0000622HP:0000622Blurred vision0TACSTD2 CL E G H4070204870Lattice corneal dystrophy Type III204870C0339273OMIM1337111530137290
HP:0000622HP:0000622Blurred vision1ABCA1 CL E G H19425ORPHA124055029600046
HP:0000622HP:0000622Blurred vision1APOA1 CL E G H335425ORPHA17794600107680
HP:0000622HP:0000622Blurred vision1ATP1A2 CL E G H477602481Familial hemiplegic migraine type 2602481C1865322OMIM199706800182340
HP:0000622HP:0000622Blurred vision1COL4A1 CL E G H1282607595Brain small vessel disease with hemorrhage607595C1843512OMIM11147842202120130
HP:0000622HP:0000622Blurred vision1HLA-A CL E G H3105179Macrothrombocytopenia progressive deafnessORPHA177184931142800
HP:0000622HP:0000622Blurred vision1KCNA1 CL E G H373637612ORPHA1483846218176260
HP:0000622HP:0000622Blurred vision1KCNA1 CL E G H3736160120Episodic ataxia type 1160120C1719788OMIM1483846218176260
HP:0000622HP:0000622Blurred vision1MAPT CL E G H4137601104Progressive supranuclear ophthalmoplegia601104C0038868OMIM11204636893157140
HP:0000622HP:0000622Blurred vision1MT-ATP6 CL E G H4508104ORPHA17414516060
HP:0000622HP:0000622Blurred vision1MT-CO1 CL E G H4512104ORPHA17419516030
HP:0000622HP:0000622Blurred vision1MT-CO3 CL E G H4514104ORPHA17422516050
HP:0000622HP:0000622Blurred vision1MT-CYB CL E G H4519104ORPHA17427516020
HP:0000622HP:0000622Blurred vision1MT-ND1 CL E G H4535104ORPHA17455516000
HP:0000622HP:0000622Blurred vision1MT-ND2 CL E G H4536104ORPHA17456516001
HP:0000622HP:0000622Blurred vision1MT-ND4 CL E G H4538104ORPHA17459516003
HP:0000622HP:0000622Blurred vision1MT-ND4L CL E G H4539104ORPHA17460516004
HP:0000622HP:0000622Blurred vision1MT-ND5 CL E G H4540104ORPHA17461516005
HP:0000622HP:0000622Blurred vision1MT-ND6 CL E G H4541104ORPHA17462516006
HP:0000622HP:0000622Blurred vision1NDUFS2 CL E G H4720104ORPHA1241357708602985
HP:0000622HP:0000622Blurred vision1NLRP3 CL E G H114548148200Keratitis fugax hereditaria148200C1835697OMIM114258316400606416
HP:0000622HP:0000622Blurred vision1NOP56 CL E G H10528276198ORPHA114315911614154
HP:0000622HP:0000622Blurred vision1SCN9A CL E G H6335133020Primary erythromelalgia133020C0014805OMIM1129142710597603415
HP:0000622HP:0000622Blurred vision1TACSTD2 CL E G H4070204870Lattice corneal dystrophy Type III204870C0339273OMIM1337111530137290
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000622HP:0000622Blurred vision0SLC12A3 CL E G H6559263800Familial hypokalemia-hypomagnesemia263800C0268450OMIM050477510912600968
HP:0000622HP:0000622Blurred vision1SLC12A3 CL E G H6559263800Familial hypokalemia-hypomagnesemia263800C0268450OMIM050477510912600968


Genes (34) :ABCA1 APOA1 ATP1A2 ATP6 CACNA1A COL4A1 COX1 COX3 CYTB HLA-A KCNA1 MAPT MT-ATP6 MT-CO1 MT-CO3 MT-CYB MT-ND1 MT-ND2 MT-ND4 MT-ND4L MT-ND5 MT-ND6 ND1 ND2 ND4 ND4L ND5 ND6 NDUFS2 NLRP3 NOP56 SCN9A SLC12A3 TACSTD2

Diseases (14) :425 602481 104 607595 179 37612 160120 601104 148200 276198 133020 263800 204870 141500
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is June 2019 release.